GPC3-IL-15 Armored CAR-T

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPC3-IL-15 Armored CAR-T, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors [Phase 1]

See pricing